National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 32 cases where Vaccine is COVID19 and Symptom is Foaming at mouth and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 3 out of 4

Result pages: prev   1 2 3 4   next


VAERS ID: 1165515 (history)  
Form: Version 2.0  
Age: 88.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-13
Onset:2021-01-23
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-04-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1484 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Acute pulmonary oedema, Drooling, Foaming at mouth, Loss of consciousness, SARS-CoV-2 test, Urinary tract infection bacterial
SMQs:, Torsade de pointes/QT prolongation (broad), Cardiac failure (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Convulsions (broad), Dyskinesia (broad), Dystonia (broad), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-10
   Days after onset: 18
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: FUROSEMIDE; ENALAPRIL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cholelithiasis; Hypertension arterial; Osteopenia; Vascular encephalopathy
Allergies:
Diagnostic Lab Data: Test Date: 20210209; Test Name: COVID-19 PCR test; Test Result: Negative
CDC Split Type: ITPFIZER INC2021342305

Write-up: first dose performed on 13Jan2021, the lady had never been infected with the virus. She was hospitalized on 09Feb2021 with loss of consciousness, she drooled in the mouth and died on 10Feb2021.; first dose performed on 13Jan2021, the lady had never been infected with the virus. She was hospitalized on 09Feb2021 with loss of consciousness, she drooled in the mouth and died on 10Feb2021.; first dose performed on 13Jan2021, the lady had never been infected with the virus. She was hospitalized on 09Feb2021 with loss of consciousness, she drooled in the mouth and died on 10Feb2021.; Acute pulmonary edema; Urinary tract infection bacterial; This is a spontaneous report received from a contactable physician downloaded from the Regulatory Authority (RA). The regulatory authority report number is IT-MINISAL02-704636. An 88-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular at the age of 88-years-old on 13Jan2021 (Lot Number: EL1484) as 0.3 mL, single for COVID-19 immunization. Medical history included Hypertension arterial, vascular encephalopathy, osteopenia, and cholelithiasis, all from an unknown date and unknown if ongoing. Concomitant medication included furosemide (FUROSEMIDE) and enalapril (ENALAPRIL); both taken for an unspecified indication, start and stop date were not reported. Clinical report request containing information relevant to the specific case, date and cause of death, which will be attached in the Regulatory Authority Center as soon as available. - Actions taken (reporting) - Covid 19 Commirnaty Vaccine (Pfizer): Booster dose number (1). Negative. The patient experienced, "first dose performed on 13Jan2021, the lady had never been infected with the virus. she was hospitalized on 09Feb2021 with loss of consciousness, she drooled in the mouth and died on 10Feb2021." The patient also experienced acute pulmonary edema and urinary tract infection bacterial both on 23Jan2021 with outcome of recovered on 04Feb2021. The patient was hospitalized for frothing at the mouth, loss of consciousness, drooling. The patient underwent lab tests and procedures which included SARS-CoV-2 test: negative on 09Feb2021. The patient died on 10Feb2021. An autopsy was not performed. Reporter''s comments: Privacy, born on Privacy, first dose performed on 13Jan2021, the lady had never been infected with the virus. She was hospitalized on 09Feb2021 with loss of consciousness, she drooled in the mouth and died on 10Feb2021. Sender''s comments: The concomitant pathologies and drugs were entered after contacting the Reporter. No further information is available. Adjustment 23Mar2021: the report sent by the Reporter is attached. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: Privacy, born on Privacy, first dose performed on 13Jan2021, the lady had never been infected with the virus. She was hospitalized on 09Feb2021 with loss of consciousness, she drooled in the mouth and died on 10Feb2021.; Reported Cause(s) of Death: Privacy., born on Privacy, first dose performed on 13Jan2021, the lady had never been infected with the virus. She was hospitalized on 09Feb2021 with loss of consciousness, she drooled in the mouth and died on 10Feb2021.; Privacy., born on Privacy, f


VAERS ID: 1388679 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-05-04
Onset:2021-05-25
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Cardiac arrest, Cardiovascular disorder, Chest pain, Circulatory collapse, Foaming at mouth, Hyperhidrosis, Malaise, Sense of oppression, Skin discolouration, Sudden death, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (narrow), Hypovolaemic shock conditions (narrow), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypoglycaemic and neurogenic shock conditions (narrow), Convulsions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (narrow), Respiratory failure (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-25
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021627720

Write-up: Retrosternal pain; tightness; Sweating; massive amounts of pink foam flowing from the mouth; Cardiac arrest; Cardiovascular disorder; Vomiting; grey colour; collapse; Sudden death; sudden unwellness; This is as spontaneous report received from a contactable physician downloaded from the regulatory authority-WEB. The regulatory authority report number is BE-FAMHP-DHH-N2021-93461. A 61-year-old male patient received BNT162B2 (COMIRNATY), first dose via an unspecified route of administration on 04May2021 (Batch/Lot Number: unknown) as single dose for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced cardiovascular disorder, unwell (sudden unwellness), cardiac arrest (immobilisation during transfer to hospital), vomiting, retrosternal pain, sweating, skin discolouration (grey colour), sense of oppression (tightness), circulatory collapse, foaming at mouth (massive amounts of pink foam flowing from the mouth), sudden death on 25May2021. The patient had suddenly unwell at work this morning on 25May2021; stopped during transfer to hospital; unsuccessful resuscitation resulting in death. The patient would not have shown any symptoms in the course of the previous days according to family. It was unclear whether there was a relation between vaccination and death. The patient died on 25May2021. It was not reported if an autopsy was performed. Relatedness of drug to reaction(s)/event(s): (All events) Source of assessment: FAMHP Method of assessment: WHO Result of assessment: unclassifiable No follow-up attempts possible. Information on lot and batch numbers cannot be obtained. ; Reported Cause(s) of Death: Sudden death; tightness; Sweating; massive amounts of pink foam flowing from the mouth; Cardiac arrest; Cardiovascular disorder; Vomiting; grey colour; collapse; sudden unwellness; Retrosternal pain


VAERS ID: 1456357 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-07-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Death, Facial asymmetry, Facial paresis, Foaming at mouth
SMQs:, Convulsions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: MYPFIZER INC2021830164

Write-up: Death; Frothing at mouth; Facial paresis; Facial asymmetry; This is a spontaneous report from a contactable pharmacist received from the Regulatory Authority. The regulatory authority report number is 21-04-02669A. A 36-year-old female patient received BNT162B2 (COMIRNATY, solution for injection, Lot number not provided), via intramuscular, on unknown date, at single dose for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. On an unknown date, 3 day after the vaccination, the patient experienced frothing at mouth (medically significant), facial paresis (medically significant), and facial asymmetry (medically significant). On unknown date, the patient experienced death. The cause of death was no provided. It was unknown if an autopsy was performed. Frothing at mouth, facial paresis, and facial asymmetry were ongoing at the time of death. No follow-up attempts are possible; information about batch/lot number cannot be obtained.; Reported Cause(s) of Death: Death


VAERS ID: 1477755 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-07-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Death, Foaming at mouth, Unresponsive to stimuli, Vomiting
SMQs:, Acute pancreatitis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Convulsions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: MYPFIZER INC2021830145

Write-up: Death; Unresponsive to stimuli; Vomiting; Frothing at mouth; This is a spontaneous report from a contactable pharmacist received from the Regulatory Authority. Regulatory authority report number is 21-04-03091A. A 44-year-old male patient received bnt162b2 (COMIRNATY, Solution for injection), via intramuscular on an unspecified date (Batch/Lot number was not reported) as a single dose for covid-19 immunization. The patient medical history was not reported. The patient''s concomitant medications were not reported. After 17 days form vaccinated, the patient experienced Vomiting, Frothing at mouth, Unresponsive to stimuli. After 18 days form vaccinated, the patient was death. All events assessed as serious, medically significant. The patient died on an unspecified date. It was unknown if an autopsy was performed. The outcome of the event death was fatal, outcome of other events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Death


VAERS ID: 1517251 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-10
Onset:2021-07-11
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-07-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FC3661 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Cardiac failure acute, Cardio-respiratory arrest, Foaming at mouth, Loss of consciousness, Malaise, Pyrexia, Unresponsive to stimuli
SMQs:, Torsade de pointes/QT prolongation (broad), Cardiac failure (narrow), Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Convulsions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-07-12
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: EFIENT
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cardiac valvulopathy (underwent surgery 3 times for cardiac valvulopathy at hospital A); Surgery
Allergies:
Diagnostic Lab Data: Test Date: 20210710; Test Name: Body temperature; Result Unstructured Data: Test Result:36.5 Centigrade
CDC Split Type: JPPFIZER INC202100909738

Write-up: cardio-respiratory arrest; unconscious/lost consciousness; did not respond to verbal stimulation; foamed at the mouth; Cardiac failure acute; feverish; malaise; This is a spontaneous report from a contactable physician received from the regulatory authority. The regulatory authority report number is v21120106. An 86-year and 11-month female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 10Jul2021 (Batch/Lot Number: FC3661; Expiration Date: 30Sep2021) as dose 2, single for COVID-19 immunisation. Medical history included cardiac valvulopathy: The patient underwent surgery 3 times for cardiac valvulopathy at hospital A. She was still regularly visiting the hospital. The patient regularly visited hospital for the treatment of cardiac disease. Concomitant medication included prasugrel hydrochloride (EFIENT) tablet 5 mg. The patient received the first dose of Comirnaty on 19Jun2021. Body temperature before second vaccination was 36.5 degrees centigrade. On 10Jul2021 (the day of vaccination), the patient received the second dose of BNT162b2 (COMIRNATY, Lot# FC3661, Expiration date 30Sep2021) via an unspecified route of administration as a single dose for COVID-19 immunization. On 12Jul2021, in the evening, (2 days after the vaccination), the patient experienced acute cardiac failure. On 12Jul2021 at 19:23, (2 days after the vaccination), the outcome of the events (Cardiac failure acute and cardio-respiratory arrest) was fatal. The course of the event was as follows: On 19Jun2021, the patient received the first dose of BNT162b2. On 10Jul2021, early in the morning, the patient had edema in her limbs and visited the emergency unit of hospital A. On 10Jul2021, in the afternoon, the patient received the second dose of BNT162b2. No changes were noted in the patient''s conditions while she was in the vaccination site and also after she went back home. On 11Jul2021, the patient was feverish and had malaise, but she was able to eat meals and drink water. On 12Jul2021, at 18:00, the patient''s family member found her unconscious in her room.. She foamed at the mouth. lost consciousness, and did not respond to verbal stimulation. Her family member asked for ambulance, and she was transferred to hospital B (The patient''s physician was in hospital A, but since they considered that the patient''s conditions required to be urgently treated, she was transferred to hospital B).At 18:56, when the ambulance arrived at the hospital, the patient had cardio-respiratory arrest. Resuscitative maneuver was performed, but no response was noted. At 19:23, the patient was confirmed dead at hospital B. The cause of death was acute cardiac failure. The reporting physician classified the events (Cardiac failure acute and cardio-respiratory arrest) as serious (death) and considered the causality of the event to BNT162b2 as unassessable. Other possible cause of the event such as any other diseases was also unassessable. The outcome of feverish, malaise, lost consciousness, foamed at the mouth and did not respond to verbal stimulation was unknown.; Reported Cause(s) of Death: Cardiac failure acute


VAERS ID: 1517329 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-02
Onset:2021-07-04
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-07-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0207 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure decreased, Blood pressure measurement, Body temperature, C-reactive protein, C-reactive protein increased, Cardiac arrest, Coma scale, Computerised tomogram, Foaming at mouth, Hypopnoea, Loss of consciousness, Osteomyelitis, Oxygen saturation, Pneumonia, Pyrexia, Unresponsive to stimuli
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Convulsions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Osteonecrosis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (narrow), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-07-04
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Cardiac failure chronic; Renal failure (being treated with Dialysis at the time of vaccination)
Preexisting Conditions: Medical History/Concurrent Conditions: Dialysis
Allergies:
Diagnostic Lab Data: Test Date: 20210704; Test Name: BP; Result Unstructured Data: Test Result: 97/43 mmHg; Test Date: 20210702; Test Name: body temperature; Result Unstructured Data: Test Result:36.6 Centigrade; Comments: before vaccination; Test Date: 20210704; Test Name: body temperature; Result Unstructured Data: Test Result: 38.6 Centigrade; Test Date: 20210704; Test Name: JCS; Result Unstructured Data: Test Result: 3-300; Test Date: 20210704; Test Name: CT; Result Unstructured Data: Test Result: showed pneumonia image on the right lower lung; Test Date: 20210704; Test Name: CRP; Result Unstructured Data: Test Result: 472; Comments: unit illegible; Test Date: 20210704; Test Name: SpO2; Test Result: 93%; Comments: 8 L/m RM.
CDC Split Type: JPPFIZER INC202100918002

Write-up: Osteomyelitis of toes; foaming at the mouth; unconscious; pneumonia image on the right lower lung; no reaction to pain stimulation; body temperature was 38.6 degrees Celsius; blood pressure was 97/43 mmHg; shallow spontaneous respiration was observed.; mild increase of C-reactive protein to 472; Cardiac arrest; This is a spontaneous report from a contactable physician received from the Regulatory Authority. The Regulatory authority report number is v21120290. The report was also received from a healthcare professional via a representative. An 86-year-old female patient received BNT162B2 (COMIRNATY), via an unspecified route of administration on 02Jul2021 (Lot Number: EW0207; Expiration Date: 30Sep2021) as dose 2, single for COVID-19 immunisation. Medical history included ongoing cardiac failure chronic and ongoing renal failure (being treated with dialysis at the time of vaccination). Body temperature before vaccination was 36.6 degrees centigrade (02Jul2021). The patient family history was not provided. Heart disorder, renal disease, Dialysis at the time of vaccination, antithrombogenic drug were reported on the vaccine screening questionnaire. On an unknown date, the patient previously received the first dose of BNT162b2 (COMIRNATY, Lot# and Expiration date were not provided) for COVID-19 immunisation. On 02Jul2021 (the day of vaccination) at unspecified time in the afternoon, the patient received the second dose of BNT162b2 (COMIRNATY, Solution for injection, Lot number EW0207, Expiration date 30Sep2021) via an unspecified route of administration as a single dose for COVID-19 immunization. On 04Jul2021 at 04:00 (two days after the vaccination), the patient experienced Other Reactions. On 04Jul2021 (two days after the vaccination), the patient was admitted to the hospital. On 04Jul2021 (two days after the vaccination), the outcome of the event was fatal. The course of the event was as follows: The patient was under the treatment for Cardiac failure chronic and Renal failure (Dialysis). On 04Jul2021 (two days after the vaccination) at 04:00, the family of the patient found the patient foaming at the mouth and being unconscious and called an ambulance. At 05:45, the patient was transferred to the hospital. On arrival, Scale was 3-300 (no reaction to pain stimulation), body temperature was 38.6 degrees Celsius, blood pressure was 97/43 mmHg, oxygen saturation (SpO2) was 93% (8 L/m RM), shallow spontaneous respiration was observed. Blood test showed mild increase of C-reactive protein to 472 (unit illegible), Computerised tomogram showed pneumonia image on the right lower lung. The patient was admitted to the hospital and received the respiratory treatment with BiBAP. After that, Cardiac arrest was observed. The reporting physician classified the event as serious (fatal) and assessed that the causality between the event and BNT162b2 as unassessable. Other possible cause(s) of the event such as any other diseases were Cardiac failure chronic, Renal failure, Osteomyelitis of toes and Pneumonia. The reporting physician did not provide any further comment. On 04Jul2021, the patient died due to cardiac arrest, while unknown outcome for the remaining events. It was unknown if an autopsy was performed. Reported Cause(s) of Death: Cardiac arrest.


VAERS ID: 1533593 (history)  
Form: Version 2.0  
Age: 96.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-21
Onset:2021-07-21
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FD0889 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Asphyxia, Body temperature, Cardio-respiratory arrest, Foaming at mouth, Multiple organ dysfunction syndrome, Pallor, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Convulsions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Sepsis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-07-21
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: PREDONINE [PREDNISOLONE]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anti-neutrophil cytoplasmic antibody positive vasculitis
Allergies:
Diagnostic Lab Data: Test Date: 20210721; Test Name: Body temperature; Result Unstructured Data: Test Result: 36.9 Centigrade; Comments: before vaccination.
CDC Split Type: JPPFIZER INC202100943885

Write-up: Multi-organ failure resulting from asphyxia due to vomiting; Multi-organ failure resulting from asphyxia due to vomiting; Multi-organ failure resulting from asphyxia due to vomiting; cardio-respiratory arrest; Complexion ill; Foaming at mouth; This is a spontaneous report from a contactable physician received from the Regulatory Authority. Regulatory authority report number is v21120990. A 96-year and 3-month-old female patient received BNT162B2 (COMIRNATY, Solution for injection), via an unspecified route of administration on 21Jul2021 at 14:17 (Batch/Lot Number: FD0889; Expiration Date: 30Sep2021) (at the age of 96-years-old) as dose 1, single for COVID-19 immunisation. Body temperature before vaccination was 36.9 degrees centigrade. Family history was unknown. Medical history included antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Concomitant medications included prednisolone (PREDONINE) orally ongoing at 6 mg/day taken for an unspecified indication, start and stop date were not reported. On 21Jul2021, the patient experienced complexion ill and foaming at mouth at 14:22 (5 minutes after the vaccination). On 21Jul2021, the patient died with multi-organ failure resulting from asphyxia due to vomiting. The course of the events was as follows: On 21Jul2021 at 14:17 (the day of vaccination), the patient received the coronavirus vaccination. At 14:22 (5 minutes after the vaccination), complexion ill was noted. The patient was found foaming at the mouth. At 14:25 (8 minutes after the vaccination), medical review was done in a sitting position. The carotid artery was not palpable at that time. At 14:28 (11 minutes after the vaccination), the reporting physician was called, went to hospital. The physician assessed the patient was in cardio-respiratory arrest. At 14:30 (13 minutes after the vaccination), cardiac massage was started by another person. At 14:33 (16 minutes after the vaccination), an ambulance was called. At 14:35 (18 minutes after the vaccination), an automated external defibrillator (AED) was used, but no improvement was obtained. The reporting physician classified the events as serious (hospitalization) and assessed the causality between the events and BNT162b2 as unassessable. Other possible cause of the event such as any other diseases included asphyxia due to vomiting. The patient died on 21Jul2021. It was not reported if an autopsy was performed. The reporting physician commented as follows: The information was from Primary care. There was a contact from the hospital where the patient was urgently taken, and it notified that the death cause was multi-organ failure resulting from asphyxia due to vomiting.; Reporter''s Comments: The information was from Hospital. There was a contact from the hospital where the patient was urgently taken, and it notified that the death cause was multi-organ failure resulting from asphyxia due to vomiting.; Reported Cause(s) of Death: Multi-organ failure resulting from asphyxia due to vomiting; Multi-organ failure resulting from asphyxia due to vomiting; Multi-organ failure resulting from asphyxia due to vomiting


VAERS ID: 1534627 (history)  
Form: Version 2.0  
Age: 64.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-21
Onset:2021-07-21
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE2090 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Death, Fatigue, Foaming at mouth, SARS-CoV-2 antibody test positive, SARS-CoV-2 test
SMQs:, Convulsions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Generalised convulsive seizures following immunisation (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetes mellitus (On treatment); Hypertension (On tdreatment)
Allergies:
Diagnostic Lab Data: Test Date: 20210722; Test Name: SARS-COV-2 PCR; Result Unstructured Data: Test Result:POSITIVE
CDC Split Type: ZAPFIZER INC202100971580

Write-up: Demised; COVID-19 antibody test positive; Tiredness; General body weakness; Foaming from mouth; This is a spontaneous report from a non-contactable consumer. A 64-year-old female patient (unknown pregnant) received the second dose of BNT162b2 via an unspecified route of administration on 21Jul2021 at 09:00 (Batch/Lot Number: FE2090; Expiration Date: Oct2021) as single for COVID-19 immunization. Medical history included hypertension and diabetes mellitus, both on treatment. The patient''s concomitant medications were not reported. On 21Jul2021 at 15:00, the patient experienced tiredness and general body weakness. On 21Jul2021, the patient was also foaming from mouth. On an unspecified date, the patient was found demised in the sitting poisition at home. The patient had a COVID-19 antibody positive test on 22Jul2021 (test done in the mortuary). Tests Sars-cov-2 test: positive on 22Jul2021. It was not reported if an autopsy was performed. The outcome of death was fatal, the outcome of other events was unknown.; Reported Cause(s) of Death: death


VAERS ID: 1539035 (history)  
Form: Version 2.0  
Age: 79.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-07-30
Onset:2021-07-31
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-08-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FD1945 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Cardio-respiratory arrest, Foaming at mouth, Loss of consciousness, Physical deconditioning
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Convulsions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Respiratory failure (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-07-31
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cardiac failure; Oxygen therapy (home oxygen)
Allergies:
Diagnostic Lab Data: Test Date: 20210730; Test Name: body temperature; Result Unstructured Data: Test Result:36.2 Centigrade; Comments: before vaccination
CDC Split Type: JPPFIZER INC202100986362

Write-up: cardiopulmonary arrest; lost consciousness; forming at the mouth; physical deconditioning; This is a spontaneous report from a contactable physician received from the Regulatory Authority. Regulatory authority report number is v21122080. A 79-year-old (reported as 79-year and 5-month-old) male patient received bnt162b2 (COMIRNATY, Solution for injection, Lot number FD1945, Expiration date 31Oct2021), dose 2 via an unspecified route of administration on 30Jul2021 as single dose for covid-19 immunisation. Medical history included cardiac failure, oxygen therapy (home oxygen). The patient''s concomitant medications were not reported. The patient previously received first dose of bnt162b2 on an unspecified date for COVID-19 immunisation. On 30Jul2021 in the morning (the day of vaccination), the patient received the second dose of bnt162b2. Body temperature before vaccination was 36.2 degrees centigrade. On 31Jul2021 at 18:43 (one day after the vaccination), the patient died. The outcome of the event was fatal. The course of the patient''s death was as follows: On 30Jul2021, the patient received the second dose of COVID-19 Vaccine. Since the morning on 31Jul2021, physical deconditioning had occurred. At 17:00, the patient lost consciousness with forming at the mouth, and emergency squad was called. When the arrival of the emergency squad, the patient had cardiopulmonary arrest (CPA). At 18:43, the patient was confirmed dead at hospital. The outcome of event cardiopulmonary arrest was fatal, the rest of events outcome was unknown. The reporting physician classified the event as serious (death) and assessed that the causality between the event and BNT162b2 as un-assessable. Other possible causes of the event such as any other diseases were cardiac failure chronic, COPD and diabetes mellitus (DM). The reporting physician commented as follows: The relationship to the vaccination was not clear, but the reporter reported the case because it was the day after the vaccination.; Reported Cause(s) of Death: cardiopulmonary arrest


VAERS ID: 1796951 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-08-26
Onset:2021-08-28
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-10-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Cardiac arrest, Chest discomfort, Depressed level of consciousness, Dyspnoea, Foaming at mouth, Malaise
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Convulsions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Respiratory failure (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-08-28
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NZPFIZER INC202101360581

Write-up: depressed level of consciousness/barely conscious; chest discomfort; dyspnoea/SOB; frothing at the mouth; asystole; felt unwell; This is a spontaneous report from a contactable physician (general practitioner). Regulatory authority report number is AEFI-A-013494. An 84-year-old female patient received bnt162b2, via an unspecified route of administration on 26Aug2021 (batch/lot number was not reported) as dose 2, single for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 28Aug2021 14:30, the patient experienced depressed level of consciousness, chest discomfort, dyspnoea. The reporter informed that the patient felt unwell and a bit SOB mid morning, son arrived before lunch and last seen a live at around 1:30 PM. The son called back again perhaps an hour later to find her sitting on the side of the bed frothing at the mouth and barely conscious, called an ambulance, then just seemed to fade away. When the ambulance arrived, the patient was in asystole, did CPR for 30 minutes without success. The previous night had been seen and they thought she was in good spirits and seems pretty well, no complaints of chest pain or SOB. The patient died on 28Aug2021 approximately 3:30 PM. It was unknown if an autopsy was performed. The physician informed that the events was unrelated to Med. Reporter''s description of AEFI: Copy of my notes S: Written in retrospect Call from son to say his mother had died approximately 3:30 PM. He had called to say, she felt unwell and a bit SOB mid morning, son arrived before lunch and last seen a live at around 1:30 PM, Son called back again perhaps an hour later to find her sitting on the side of the bed frothing at the mouth and barely conscious, called an ambulance, then just seem to fade away, When ambulance arrived was in asystole, did CPR for 30 minutes without success Previous night had been seen and they thought she was in good spirits and seems pretty well, no complaints of chest pain or SOB O: Confirm deceased, multiple extended family present P: Agreed I was happy to do death certificate, for burial Of note, had 2nd C 19 vaccination 26/8/21, no complaints about it afterwards, and although I do not think the 2 are necessarily related, on balance should be notified to CIR. Reporter type: General Practitioner. The events occurred in a country different from that of the reporter. This may be a duplicate report if another reporter from the country where the event occurred has submitted the same information to his/her local agency. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender''s Comments: Based on the information available and a possible contributory role of the suspect BNT162B2 to the reported events can be completely excluded/unrelated.; Reported Cause(s) of Death: felt unwell; frothing at the mouth; asystole; Depressed level of consciousness/barely conscious; Chest discomfort; Dyspnoea/SOB


Result pages: prev   1 2 3 4   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=3&SYMPTOMS=Foaming_at_mouth_%2810062654%29&VAX=COVID19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166